KalVista Pharmaceuticals to Report Eight Months Fiscal Year 2025 Financial Results and Provide Corporate Update on March 25, 2026
Go back to KalVista Pharmaceuticals to Report Eight Months Fiscal Year 2025 Financial Results and Provide Corporate Update on March 25, 2026| (NASDAQ: KALV) | Delayed: 27.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.00 | 52 Week High | $ | |||
| Open | $27.00 | 52 Week Low | $ | |||
| Day High | $27.00 | P/E | N/A | |||
| Day Low | $27.00 | EPS | $ | |||
| Volume | 250 | |||||
